THE United States (US) injected US$341 million into Zimbabwe’s healthcare sector in 2020 alone to mitigate the treatment of HIV, tuberculosis (TB) and malaria cases last year alone. This comes as HIV prevalence in Zimbabwe declined to 12,9 percent from a high of 29 percent in 1999 with up to 339 multi-drug resistant TB patients…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions